Nielsen Henriette Svarre, Steffensen Rudi, Varming Kim, Van Halteren Astrid G S, Spierings Eric, Ryder Lars P, Goulmy Els, Christiansen Ole Bjarne
The Fertility Clinic, University Hospital Copenhagen, Rigshospitalet, Denmark.
Hum Mol Genet. 2009 May 1;18(9):1684-91. doi: 10.1093/hmg/ddp077. Epub 2009 Feb 17.
Healthy females, pregnant with a boy, generate immune responses against male-specific minor histocompatibility (HY) antigens. The clinical importance of these responses is evident in stem cell transplantation. Birth of a boy prior to a series of miscarriages reduces the chance of a subsequent live birth. This study explores the putative impact of known HY-presenting HLA alleles on future pregnancy outcome in women with at least three consecutive miscarriages following a birth [secondary recurrent miscarriage (SRM)]. HLA-A, -B, -DRB1, DRB3-5 and DQB1 genotyping was performed in 358 SRM patients and in 203 of their children born prior to the miscarriages. The subsequent live birth in women with boys prior to the miscarriages compared with girls is lower in women with HY-restricting HLA class II alleles [odds ratio (OR): 0.17 (0.1-0.4), P = 0.0001]. One HY-restricting HLA class II allele in women with firstborn boys significantly reduces the chances of a live birth [OR: 0.46 (0.2-0.9), P = 0.02]. Two HY-restricting HLA class II alleles further reduced this chance [OR: 0.21 (0.1-0.7), P = 0.02]. HY-restricting HLA class II did not reduce the chances of a live birth in SRM women with firstborn girls. HY-restricting HLA class II alleles are associated with a decreased chance of a live birth in SRM women with firstborn boys. These findings strongly indicate an aberrant maternal immune reaction against fetal HY-antigens in SRM. The results may shed light on the as-yet unknown immunological causes of SRM and may help understand the successful maternal acceptance of the fetal semi-allograft.
怀有男胎的健康女性会产生针对男性特异性次要组织相容性(HY)抗原的免疫反应。这些反应在干细胞移植中的临床重要性是显而易见的。在一系列流产之前生下男孩会降低随后活产的几率。本研究探讨了已知的呈递HY的HLA等位基因对经历过一次分娩后至少连续三次流产的女性(继发性复发性流产,SRM)未来妊娠结局的假定影响。对358例SRM患者及其流产前出生的203名子女进行了HLA - A、- B、- DRB1、DRB3 - 5和DQB1基因分型。在流产前怀有男孩的女性中,与怀有女孩的女性相比,具有限制HY的HLA II类等位基因的女性随后活产的几率更低[比值比(OR):0.17(0.1 - 0.4),P = 0.0001]。头胎为男孩的女性中存在一个限制HY的HLA II类等位基因会显著降低活产几率[OR:0.46(0.2 - 0.9),P = 0.02]。两个限制HY的HLA II类等位基因会进一步降低这种几率[OR:0.21(0.1 - 0.7),P = 0.02]。限制HY的HLA II类等位基因并没有降低头胎为女孩的SRM女性的活产几率。限制HY的HLA II类等位基因与头胎为男孩的SRM女性活产几率降低有关。这些发现强烈表明SRM患者母体对胎儿HY抗原存在异常免疫反应。这些结果可能有助于揭示SRM尚未明确的免疫原因,并可能有助于理解母体对胎儿半同种异体移植物的成功接受。